Full View

Quantitative Hepatitis B Surface Antigen Analysis in Hepatitis BE Antigen-Positive Nucleoside-Naive Patients Treated with Entecavir

RG Gish, TT Chang, CL Lai, RA De Man… - Antiviral …, 2013 - journals.sagepub.com
Background Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …
被引用次数：29 相关文章

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, RA de Man… - Antiviral …, 2013 - nckur.lib.ncku.edu.tw
Background: Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, T Chang, C Lai, R de Man, A Gadano… - Antiviral …, 2013 - repub.eur.nl
Background: Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …

[引用][C] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive, nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, RA de Man, A Gadano… - Antiviral …, 2013 - hub.hku.hk
HKU Scholars Hub: Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive,
nucleoside-naive patients treated with entecavir Skip navigation HKU Login Guest Login …
[PDF] researchgate.net

[PDF][PDF] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, RA de Man, A Gadano… - 2013 - researchgate.net
Background: Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, A Robert… - Antiviral …, 2013 - researchoutput.ncku.edu.tw
Background: Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …

[引用][C] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG GISH, TT CHANG, CL LAI… - Antiviral therapy …, 2013 - pascal-francis.inist.fr
Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive
patients treated with entecavir CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir.

RG Gish, TT Chang, CL Lai, RA de Man… - Antiviral …, 2013 - europepmc.org
Background Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …
[PDF] archive.org

[PDF][PDF] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, RA de Man… - Antiviral …, 2013 - scholar.archive.org
Background: Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …

Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir

RG Gish, TT Chang, CL Lai, RA de Man… - Antiviral …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Entecavir is a potent nucleoside analogue for treating chronic hepatitis B
(CHB). Quantitative hepatitis B surface antigen (qHBsAg) levels are predictive of response to …